MIRA Pharmaceuticals, Inc.
MIRA
$0.78
$0.034.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -89.14% | 489.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -81.06% | 342.28% | |||
| Operating Income | 81.06% | -342.28% | |||
| Income Before Tax | 80.78% | -425.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 80.78% | -425.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.78% | -425.91% | |||
| EBIT | 81.06% | -342.28% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 81.31% | 87.55% | |||
| Normalized Basic EPS | 80.66% | -107.51% | |||
| EPS Diluted | 81.31% | 87.55% | |||
| Normalized Diluted EPS | 80.66% | -107.51% | |||
| Average Basic Shares Outstanding | 2.74% | 111.80% | |||
| Average Diluted Shares Outstanding | 2.74% | 111.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||